Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00479765
Status:
TERMINATED
Last Update Posted:
2022-06-22
First Post:
2007-05-24
Brief Title:
A Phase 1 2 Dose Escalation Study of Locally-Administered OncoGel in Subjects With Recurrent Glioma
Sponsor:
Boston Scientific Corporation
Organization:
Boston Scientific Corporation
Organization Data
Organization:
Boston Scientific Corporation
Class:
INDUSTRY
Study ID:
PR016-CLN-pro002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Boston Scientific Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None